300253 卫宁健康
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.251-6.4751.5096.6312.128
总资产报酬率 ROA (%)0.167-4.3271.0164.3731.418
投入资产回报率 ROIC (%)0.197-5.1551.2165.2671.686

边际利润分析
销售毛利率 (%)30.77332.82941.68044.96843.689
营业利润率 (%)-3.359-19.8533.13310.7931.277
息税前利润/营业总收入 (%)0.519-18.0585.19012.3862.529
净利润/营业总收入 (%)-0.337-18.2401.80010.0400.477

收益指标分析
经营活动净收益/利润总额(%)496.95649.044309.415104.088685.880
价值变动净收益/利润总额(%)59.98711.415-88.356-6.153-234.982
营业外收支净额/利润总额(%)0.6255.500-0.245-0.201-2.493

偿债能力分析
流动比率 (X)3.1332.8313.0962.8422.725
速动比率 (X)3.0612.7733.0292.7772.663
资产负债率 (%)32.65734.34932.23633.54434.455
带息债务/全部投入资本 (%)20.32720.49517.41417.50818.975
股东权益/带息债务 (%)385.858382.012464.498458.427413.878
股东权益/负债合计 (%)206.564190.816211.201198.318189.610
利息保障倍数 (X)0.133-6.1192.5147.6711.972

营运能力分析
应收账款周转天数 (天)237.962190.190149.022116.15795.364
存货周转天数 (天)34.10126.89824.61121.53223.832